Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients.

The remaining ASOs showed limited HTT silencing and specificity that did not reach statistical significance with two-way ANOVA and Bonferroni post hoc test ( Figure S2 ).

also in 111,027 other papers